Clinical Trial Update: A Phase II Multi-institutional Study Assessing Simultaneous In-field Boost Helical Tomotherapy for 1-3 Brain Metastases [Phase 2]

View source ↗

Summary

A Phase II multi-institutional trial evaluating simultaneous in-field boost with Helical Tomotherapy for patients with 1-3 brain metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Metastasis to Brain of Primary Cancer | Phase 2 | Status: COMPLETED